RSS Feeds
Search

Companies

Companies

Displaying 1..10 of 24 - per page Next page
Order by
Profiled on medicaldevicelicensing.com APR Applied Pharma Research S.A.
APR is a private, independent, integrated Healhcare Company focused on Delivering, Funding and Supporting Innovation in Healthcare. More
Profiled on medicaldevicelicensing.com Amarin Technologies S.A.
Amarin is engaged in the development of innovative pharmaceutical products using its proprietary topical and transdermal drug delivery technologies and know-how. More
Profiled on medicaldevicelicensing.com Labtec GmbH
Labtec GmbH provides innovative Product Development and Manufacturing Services all over the world. More
Penwest Pharmaceuticals
Penwest is a specialty pharmaceutical company dedicated to bringing to the marketplace innovative products that help improve the lives of patients. More
GALENIX
Galenix is a key-partner in pharmaceutical Research and Development More
B. Braun Melsungen AG
Based on the expertise of B. Braun, one of the world's leading healthcare providers, the OEM Division supplies system-built outsourcing solutions to the pharmaceutical industry. More
Biomedica Foscama
Biomedica Foscama is committed in development, production and marketing of prescription pharmaceuticals. The main focus is on cardiovascular, CNS, GI/metabolism and hospital products. More
PSI n.v. and PSI supply n.v.
A broad-spectrum provider of pharmaceutical services and off-patent medicinal products. More
Pharmathen
Development & Marketing of Pharmaceuticals More
Lay Line Genomics
Lay Line Genomics S.p.A. (LLG) is a biopharmaceutical company focused on the discovery and development of innovative therapies for Alzheimer's and other neurological diseases. More
Displaying 1..10 of 24 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
Company Financials: Alexza Pharmaceuticals
Jan 2010 - $75
Company Financials: Orexigen Therapeutics, Inc.
Jan 2010 - $75
Forest Laboratories: Pipeline, Products, Performance, Potential
Feb 2009 - 66 pages - $1,040
Lundbeck: Pipeline, Products, Performance, Potential
Jun 2010 - 70 pages - $1,040
Company Financials: Cephalon, Inc
Jan 2010 - $75
World Market for Prescription Generic Drugs, 6th Edition
Apr 2008 - 250 pages - $3,995
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us